Difference between revisions of "LINC02470"

From LncRNAWiki
Jump to: navigation, search
(Created page with "''LINC02470'', is a long non-coding RNA and involved in cisplatin resistance. ==Annotated Information== ===Name=== ''LINC02470'': long intergenic non-protein coding RNA 2470...")
 
 
(One intermediate revision by one other user not shown)
Line 3: Line 3:
 
==Annotated Information==
 
==Annotated Information==
 
===Name===
 
===Name===
''LINC02470'':  long intergenic non-protein coding RNA 2470 <ref name="ref1" />
+
Approved symbol:LINC02470
AC091814.2 (HGNC).
 
  
 +
Approved name:long intergenic non-protein coding RNA 2470
 +
 +
HGNC ID :HGNC:53409
 +
 +
Alias symbol:AC091814.2
 +
 +
RefSeq ID:NR_104634
 
===Characteristics===
 
===Characteristics===
 
''LINC02470'' is 992 bp long non-coding RNA, located on chromosome  chr12p13.31, consisting five exons (GenBank).  
 
''LINC02470'' is 992 bp long non-coding RNA, located on chromosome  chr12p13.31, consisting five exons (GenBank).  

Latest revision as of 12:25, 25 January 2021

LINC02470, is a long non-coding RNA and involved in cisplatin resistance.

Annotated Information

Name

Approved symbol:LINC02470

Approved name:long intergenic non-protein coding RNA 2470

HGNC ID :HGNC:53409

Alias symbol:AC091814.2

RefSeq ID:NR_104634

Characteristics

LINC02470 is 992 bp long non-coding RNA, located on chromosome chr12p13.31, consisting five exons (GenBank).

Function

Please input information here

Expression

Please input information here

Regulation

LINC02470 is directly controlled by DNA methylation [1].

Diseases

  • Non-small cell lung cancer (NSCLC) and overian cancer [1]

Labs working on this lncRNA

  • Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain.[1]
  • Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.[1]
  • Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.[1]
  • Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.[1]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Vera O, Rodriguez-Antolin C, de Castro J, Karreth FA, Sellers TA & de Caceres II. An epigenomic approach to identifying differential overlapping and cis-acting lncRNAs in cisplatin-resistant cancer cells[J]. Epigenetics-Us. 2018, 13(3):251-263.

Sequence

>gi|100506159|ref|NR_104634.2| Homo sapiens long intergenic non-protein coding RNA 2470 (LINC02470), long non-coding RNA

000001 GTGCATGCCC GGCTGCCGTT GCTGCCCCTG CCTCGTACAA ACGTCAGAGA AGGCACATGA CACGCCCCTG GGGGCCATCT 000080
000081 GGCCCAAGTC CACCTGCGCG GCTGAGTGGA GGATGCTAGG TTGCTGTGCT GTTTCTCCTA CTGTCTTGCT GCCGCACCAC 000160
000161 CCCTCAGAAA AACCGGGTCG TCAGTTTCCT GCGGTTTGCA CTCACCAAAT ATACTTAGCA ATTTGCAATT CACCCGCAGG 000240
000241 ATTATTCCAG CCTCTGTGAT CACACACAGA AGGATGAGCC TTCCTCGTGA GGGTTGGAGA TGGAGGGAGA AGGGATGGAG 000320
000321 AGTAAGGATG GGACGGAGGT TGTGGAGCAG CAGACCAACA CGCCAGAAAG GAAAATAATG ATCATCTCAA TTTTTATATG 000400
000401 TGGAGGCATT GCTTTTCTTC TTTGGGGGAT TTTAAGATTT CCCAGAAAAT TTGGAATTCC AAGGCACCTT AGAAACAAGA 000480
000481 CATGCCTAGA AAATTTGACT ATGTGTCCAC AAGGCTGGAA CTGAATCAAT AATAATTGCT TCTTTCAATC TGAACATGAA 000560
000561 ACAACGTGGA TCAATGGCTG AGAAAACTGC AGAAGTTATG GATCTCTGGC CAGGCTCAAC TCTCAGAATG AAATGGGAAT 000640
000641 CTTTGATGCA TTATCTGGGG CCGTCTTTAT ATTGGTTTGA ACTGAGCAAG CACAATGCAA ACAAAACGTG GATGTGGGCA 000720
000721 GATGGAGCTA CATTCAGCAA TTGTGAAAGA ATCGAGTTTT GTGCTATGAG TCATGGGAGC AAAACGTGAG TATTTAGAAG 000800
000801 TGGAGAGGAC CACGAAGAAG GAAGCCCTGG TGACTTGAAG AAATCATGGA GAGTTCTCCG GATTCCCACA AACCTATGGG 000880
000881 GTTTAGATTC CAGCTAATAC TTACACGGGT CTCAGAAGGA CAGAGGGCAA GGGTTAACAT CTGGCTGATA TTAAAGTCTC 000960
000961 TGCACCTCTT AATATTTTAA AAAAAAAAAA AA